DEA schedule

Is Incruse Ellipta a controlled substance?

Incruse Ellipta contains umeclidinium bromide. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Incruse Ellipta (umeclidinium bromide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and umeclidinium bromide is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Incruse Ellipta?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Incruse Ellipta
SourceWhat it lists
FDA NDC directory1 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances listumeclidinium bromide is not on the list

Incruse Ellipta NDC listings

NDC listings for Incruse Ellipta
NDCProductFormStrengthLabelerDEA schedule
0173-0873Incruse Elliptaaerosol, powder62.5 ug/1GlaxoSmithKline LLCNone

Questions

Is Incruse Ellipta a controlled substance?

No. Incruse Ellipta (umeclidinium bromide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and umeclidinium bromide is not on the DEA controlled substances list.

Is Incruse Ellipta a narcotic?

No. Incruse Ellipta (umeclidinium bromide) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Anticholinergic.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Incruse Ellipta

Try it on your own data today.

Free to start. Most teams are using it the same day.